Skip to main content

Advertisement

Log in

Secondary DMEK following failed primary DMEK

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To report the outcomes of secondary Descemet Membrane Endothelial Keratoplasty (DMEK) performed for failed primary DMEK.

Methods

The medical records of all patients undergoing secondary DMEK due to failure of primary DMEK were reviewed. Reasons for failure were sought and best-corrected visual acuity (BCVA), endothelial cell density (ECD) and complications of secondary DMEK were evaluated.

Results

A total of 10 cases undergoing secondary DMEK following failed primary DMEK were identified. Presumed reasons for failure included donor ECD ≤ 2300 cells/mm2 (n = 4), difficulty during graft preparation (n = 2), graft detachment (n = 2), acute angle closure due to retroiridal air dislocation (n = 1), inverse graft positioning (n = 1) and phacoemulsification (n = 1). Eyes with low visual potential were not excluded from the study group. We should note that one patient (case no7) had both low ECD and graft detachment as reasons for failure and as a result he is counted twice.

Median BCVA (decimal fraction) increased from 0.1 (range, 0.01; 0.3) to 0.5 (0.05; 1.0) at one month and remained stable thereafter. A BCVA of 0.5 or higher was achieved in 7 cases at the final follow-up. Mean ECD fell from 2628 ± 284 cells/mm2 to 1391 ± 252cells/mm2 at 6 months (47% reduction) and 959 ± 225cells/mm2 at 24 months (64% reduction) (P ≤ 0.028). Complications included the incomplete removal of the primary graft and mild iris bleeding, decompensation of a preexisting primary open-angle glaucoma and retroiridal air dislocation.

Conclusions

Apart from low donor ECD, surgical challenges, i.e., difficulty with graft preparation, inverse graft positioning, and retroiridal air dislocation, were main reasons for failure of primary DMEK. Secondary DMEK showed a good safety profile and reasonable visual outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

All data and materials of our research are available for evaluation.

Abbreviations

DMEK:

Descemet membrane endothelial keratoplasty

BCVA:

Best-corrected visual acuity

CF:

Counting fingers

DSAEK:

Descemet stripping endothelial keratoplasty

ECD:

Endothelial cell density

CCT:

Central corneal thickness

ECL:

Endothelial cell loss

References

  1. Lovaglio B, Trindade C, Coutinho G (2019) Descemetmembrane endothelial keratoplasty (DMEK): an update on safety, efficacy and patientselection. ClinOphthalmol 13:1549–1557. https://doi.org/10.2147/OPTH.S178473

    Article  Google Scholar 

  2. Anshu A, Price MO, Price FW Jr (2012) Risk of corneal transplant rejection significantly reduced with Descemet’s membrane endothelial keratoplasty. Ophthalmology 119(3):536–540. https://doi.org/10.1016/j.ophtha.2011.09.019

    Article  PubMed  Google Scholar 

  3. Deng SX, Lee WB, Hammersmith KM et al (2018) Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the american academy of ophthalmology. Ophthalmology 125(2):295–310. https://doi.org/10.1016/j.ophtha.2017.08.

    Article  PubMed  Google Scholar 

  4. Dirisamer M, Ham L, Dapena I et al (2011) Efficacy of descemet membrane endothelial keratoplasty: clinical outcome of 200 consecutive cases after a learning curve of 25 cases. Arch Ophthalmol 129:1435–1443

    Article  Google Scholar 

  5. Guerra FP, Anshu A, Price MO et al (2011) Descemet’s membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology 118:2368–2373

    Article  Google Scholar 

  6. Peraza-Nieves J, Baydoun L, DapenaI I et al (2017) Two-year clinical outcome of 500 consecutive cases undergoing descemet membrane endothelial keratoplasty. Cornea 36(6):655–660.

    Article  Google Scholar 

  7. Price D, Kelley M, Price F Jr et al (2018) Five-year graft survival ofdescemet membrane endothelial keratoplasty (ek) versus descemet stripping ek and theeffectofdonor sex matching. Ophthalmology 125(10):1508–1514. https://doi.org/10.1016/j.ophtha.2018.03.050

    Article  PubMed  Google Scholar 

  8. Baydoun L, van Dijk K, Dapena I et al (2015) Repeat descemet membrane endothelial keratoplasty after complicated primary descemet membrane endothelial keratoplasty. Ophthalmology 122(1):8–16. https://doi.org/10.1016/j.ophtha.2014.07.024

    Article  PubMed  Google Scholar 

  9. Yoeruek E, Bartz-Schmidt KU (2013) Secondary Descemet membrane endothelial keratoplasty after failed primary Descemet membrane endothelial keratoplasty: clinical results. Cornea 32(11):1414–1417. https://doi.org/10.1097/ICO.0b013e31828321c1

    Article  PubMed  Google Scholar 

  10. Price MO, Feng MT, McKee Y et al (2015) Repeat descemet membrane endothelial keratoplasty: secondary grafts with early intervention are comparable with fellow-eye primary grafts. Ophthalmology 122(8):1639–1644. https://doi.org/10.1016/j.ophtha.2015.04.037

    Article  PubMed  Google Scholar 

  11. Dirisamer M, van Dijk K, Dapena I et al (2012) Prevention and management of graft detachment in descemet membrane endothelial keratoplasty. Arch Ophthalmol. 130(3):280–291. https://doi.org/10.1001/archophthalmol.2011.343

    Article  PubMed  Google Scholar 

  12. Dapena I, Moutsouris K, Droutsas K et al (2011) Standardized “no-touch” technique for Descemet membrane endothelial keratoplasty. Arch Ophthalmol 129(1):88–94. https://doi.org/10.1001/archophthalmol.2010.334

    Article  PubMed  Google Scholar 

  13. Lie J, Birbal R, Ham L et al (2008) Donor tissue preparation for Descemet membrane endothelial keratoplasty. Cataract Refract Surg 34(9):1578–83. https://doi.org/10.1016/j.jcrs.2008.05.036

    Article  Google Scholar 

Download references

Funding

No funding was received for this research.

Author information

Authors and Affiliations

Authors

Contributions

KD designed and conducted the study. All authors analyzed the results and prepared the manuscript.

Corresponding author

Correspondence to Ioannis Giachos.

Ethics declarations

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Droutsas, K., Alexopoulos, P., Giachos, I. et al. Secondary DMEK following failed primary DMEK. Int Ophthalmol 41, 3287–3293 (2021). https://doi.org/10.1007/s10792-021-01890-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-021-01890-2

Keywords

Navigation